Form 4: Neurocrine Biosciences Director Lyons Reports Stock Transactions
SEC Form 4
Director Gary A. Lyons reports acquisition and disposal of Neurocrine Biosciences stock and derivative securities.
Summary
- Gary A. Lyons, a director of Neurocrine Biosciences Inc. (NBIX), reported changes in beneficial ownership of the company's securities.
- On May 22, 2025, Lyons acquired 1,435 shares of common stock through the vesting of restricted stock units (RSUs).
- Following the transaction, Lyons directly owns 120,482 shares of common stock.
- Lyons also acquired 1,659 restricted stock units on May 21, 2025, which will vest on May 21, 2026.
- Additionally, Lyons acquired 3,305 non-qualified stock options on May 21, 2025, vesting in 12 monthly installments starting June 21, 2025, and expiring on May 21, 2035.
- Lyons also disposed of 1,435 restricted stock units on May 22, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of stock transactions by a company director. The acquisitions could be seen as slightly positive, but it's a routine filing.
Positives
- Acquisition of shares and derivative securities may indicate confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's views on the company's stock.
Stakeholder Impact
- The transactions may influence investor sentiment regarding Neurocrine Biosciences.
Key Dates
| Date | Description |
|---|---|
| 06/08/2012 | Date of Gary A. Lyons Revocable Living Trust U/A |
| 05/21/2025 | Date of earliest transaction; Acquisition of RSUs and stock options |
| 05/22/2025 | Date of stock acquisition through RSU vesting; Date of RSU disposal |
| 06/21/2025 | First vesting date for stock options |
| 05/21/2026 | Vesting date for RSUs |
| 05/21/2035 | Expiration date for stock options |
Keywords
Neurocrine Biosciences, NBIX, Gary Lyons, Director, Stock, Restricted Stock Units, RSU, Options, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.